Earnings Call Summary | MEDICINE MAN TECHNOLOGIES INC(SHWZ.US) Q2 2024 Earnings Conference
Earnings Call Summary | MEDICINE MAN TECHNOLOGIES INC(SHWZ.US) Q2 2024 Earnings Conference
The following is a summary of the Medicine Man Technologies, Inc. (SHWZ) Q2 2024 Earnings Call Transcript:
以下是Medicine Man Technologies, Inc.(SHWZ)2024年第二季度业绩会实录摘要:
Financial Performance:
金融业绩:
Reported Q2 2024 total revenue of $43.2 million, marking a 2% increase.
Gross profit was $19 million, equating to 44% of total revenue, a decrease from 54% year-over-year primarily due to pricing pressure and increased third-party purchasing.
Operating loss was $2.7 million, with adjusted EBITDA at $9 million or 21% of revenue. Last year, EBITDA was 33% of revenue.
Cash and cash equivalents stood at $12.3 million, with total debt at $163.4 million as of June 30, 2024.
报告2024年第二季度总营业收入为4320万美元,增长2%。
毛利润为1900万美元,占总营业收入的44%,同比下降10个百分点,主要是由于定价压力和第三方采购的增加导致。
运营亏损为270万美元,调整后EBITDA为900万美元,占营业收入的21%。去年EBITDA占营业收入的比例为33%。
截至2024年6月30日,现金及现金等价物为1230万美元,总债务为1.634亿美元。
Business Progress:
业务进展:
Closed three underperforming dispensaries and a distribution center in Colorado to prioritize core operations.
Opened a new medical and recreational dispensary in Bernalillo, New Mexico, under the Our Greenleaf banner, bringing the total to 35 dispensaries.
Implemented new LED lighting in cultivation facilities aimed at a double-digit yield improvement.
Announced debt restructuring to extend maturities for financial flexibility.
关闭了科罗拉多州的三个表现不佳的零售店和一个配送中心,以优先考虑核心业务。
在新墨西哥州伯纳利洛,以“我们的绿叶”(Our Greenleaf)的品牌开设了一家新的医疗和娱乐购物中心,使总门店数达到35家。
在种植设施中使用了新的LED照明,旨在提高两位数的产量。
宣布债务重组,以延长到期日以实现财务灵活性。
Opportunities:
机会:
Plans to refine retail strategy and drive further operating efficiencies across retail, cultivation, and manufacturing operations.
Positioned for growth and stronger profitability in the second half of 2024 through ongoing operational optimizations and new product introductions.
计划完善零售策略,并在零售、种植和制造业务方面推动进一步的营运效率。
通过持续的运营优化和新产品推出,定位于2024年下半年的增长和更强的盈利能力。
Risks:
风险:
Anticipates net new store growth shifting from positive to negative in the latter half of the year due to regulatory actions increasing enforcement and accelerating compliance checks resulting in numerous closures.
预计由于监管行动加强,加速合规检查导致数次关闭,净新店增长将从正变负。
More details: MEDICINE MAN TECHNOLOGIES INC IR
更多细节请参见MEDICINE MAN TECHNOLOGIES INC IR。
Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示:本文由AI生成。文章内容的准确性无法完全保证。有关更全面的详细信息,请参阅IR网站。本文只是为投资者提供参考,没有任何指导或推荐建议。